The willingness of some posters to show their ignorance is impressive. The FDA doesn't require a company to even do phase II trial before going onto phase III let alone complete one. As to what kind of company would do that, how about Roche. Their anti-PDL1 drug MPDL3280A is moving from phase I directly to phase III. Yeah, those guys at Roche are idiots. I believe that BMY did the same their anti-PD-1 drug Nivolumab in combination with Yervoy, jump from phase I to phase III. I guess Brystol-Myers-Squibb must be another group of morons, right? By the way, the anti-Pd-1 drugs are the hot item at ASCO this year.